IL161490A0 - Racemic tamsulosin free base and methods of making the same - Google Patents

Racemic tamsulosin free base and methods of making the same

Info

Publication number
IL161490A0
IL161490A0 IL16149002A IL16149002A IL161490A0 IL 161490 A0 IL161490 A0 IL 161490A0 IL 16149002 A IL16149002 A IL 16149002A IL 16149002 A IL16149002 A IL 16149002A IL 161490 A0 IL161490 A0 IL 161490A0
Authority
IL
Israel
Prior art keywords
making
methods
same
free base
tamsulosin free
Prior art date
Application number
IL16149002A
Other languages
English (en)
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of IL161490A0 publication Critical patent/IL161490A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42—Separation; Purification; Stabilisation; Use of additives
    • C07C303/44—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
IL16149002A 2001-10-31 2002-10-17 Racemic tamsulosin free base and methods of making the same IL161490A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33081701P 2001-10-31 2001-10-31
US10/208,009 US6835853B2 (en) 2001-10-31 2002-07-31 Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
PCT/NL2002/000660 WO2003037851A1 (en) 2001-10-31 2002-10-17 Racemic tamsulosin free base and methods of making the same

Publications (1)

Publication Number Publication Date
IL161490A0 true IL161490A0 (en) 2004-09-27

Family

ID=26902810

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16144902A IL161449A0 (en) 2001-10-31 2002-10-15 Process for resolution of tamsulosin
IL16149002A IL161490A0 (en) 2001-10-31 2002-10-17 Racemic tamsulosin free base and methods of making the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL16144902A IL161449A0 (en) 2001-10-31 2002-10-15 Process for resolution of tamsulosin

Country Status (17)

Country Link
US (2) US6835853B2 (xx)
EP (2) EP1444198A1 (xx)
CN (2) CN100343227C (xx)
AT (2) ATE417822T1 (xx)
AU (2) AU2002330774B9 (xx)
CA (2) CA2464648C (xx)
CH (3) CH697164A5 (xx)
CZ (2) CZ13580U1 (xx)
DE (3) DE60230438D1 (xx)
DK (2) DK200200339U3 (xx)
FI (2) FI5957U1 (xx)
FR (2) FR2832147B1 (xx)
IL (2) IL161449A0 (xx)
IS (2) IS6603A (xx)
NL (2) NL1021671C2 (xx)
NO (1) NO20042256L (xx)
WO (2) WO2003037850A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2200699B1 (es) * 2002-07-12 2005-10-01 Ragactives, S.L Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.
USH2154H1 (en) * 2003-10-08 2006-04-04 Farmak, A.S. Process for preparing R- and S-isomers of (R)-5-(2-( (2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
SI21656A (sl) * 2003-12-29 2005-06-30 LEK farmacevtska družba d.d. Priprava (R)-5-(2-(2-(2-etoksifenoksi) etilamino)-1-propil)-2-metoksibenzensulfonamida hidroklorida z visoko kemijsko čistoto
SI21702A (en) * 2004-01-29 2005-08-31 Lek Farmacevtska Druzba Dd Preparation of amorphous form of tamsulosin
WO2005089511A2 (en) * 2004-03-19 2005-09-29 Transform Pharmaceuticals, Inc. Novel pharmaceutical forms, and methods of making and using the same
CN100545148C (zh) 2004-08-16 2009-09-30 神隆新加坡私人有限公司 一种抗良性前列腺肥大药物坦索罗辛之合成方法
US7238839B2 (en) 2004-10-07 2007-07-03 Divi's Laboratories Limited Process for the resolution of racemic (R,S) -5-(2-(2-(2- ethoxyphenoxy) ethylamino)Propyl)-2-methoxybenzene sulfonamide (tamsulosin), its novel R and S isomers and their salts and processes for their preparation
PT103216B (pt) 2004-12-06 2010-05-19 Hovione Farmaciencia S A Preparação de tamsulosin
WO2006117662A2 (en) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Polymorphic forms of (r)-(-)-tamsulosin
US20090137844A1 (en) * 2005-06-15 2009-05-28 Fermion Oy Crystallization process
EP2026766A1 (en) 2006-05-17 2009-02-25 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
US20080312328A1 (en) * 2007-06-14 2008-12-18 Protia, Llc Deuterium-enriched tamsulosin
DE102008002409A1 (de) * 2008-06-13 2009-12-17 Evonik Goldschmidt Gmbh Enzymatische Synthese von Sphingolipiden
US8465770B2 (en) * 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
EP2338876A1 (en) 2009-12-22 2011-06-29 LEK Pharmaceuticals d.d. Tamsulosin adipate for pharmaceutical use
KR101525493B1 (ko) * 2013-01-02 2015-06-03 보령제약 주식회사 고순도 탐술로신 또는 이의 염 제조방법
CN104926699B (zh) * 2015-07-02 2018-09-25 成都丽凯手性技术有限公司 一种高光学纯度盐酸坦索罗辛的制备方法
CN106631918B (zh) * 2016-10-13 2018-07-13 深圳万和制药有限公司 拆分坦索罗辛对映异构体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH383998A (de) * 1959-08-05 1964-11-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
US3261829A (en) * 1964-08-12 1966-07-19 Searle & Co Spiro(steroidal-6,3'-1-pyrazolines) and process
CA1147342A (en) 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
JPS56110665A (en) 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
JPH066565B2 (ja) 1986-07-21 1994-01-26 山之内製薬株式会社 光学活性なベンゼンスルホンアミド誘導体の製造法
ES2098069T3 (es) * 1993-02-23 1997-04-16 Hoechst Ag Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos.
US5914349A (en) * 1994-01-10 1999-06-22 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

Also Published As

Publication number Publication date
FR2832147B1 (fr) 2006-06-02
CA2464917A1 (en) 2003-05-08
FR2832146A1 (fr) 2003-05-16
AU2002330776B2 (en) 2009-03-12
NO20042256L (no) 2004-07-28
NL1021671C2 (nl) 2003-05-15
ATE417822T1 (de) 2009-01-15
FI5816U1 (fi) 2003-06-06
DK200200338U3 (da) 2003-07-11
DK200200339U3 (da) 2003-06-13
DK200200338U1 (da) 2003-01-31
IS6602A (is) 2003-05-02
CA2464917C (en) 2009-06-02
CN100579958C (zh) 2010-01-13
EP1444199B1 (en) 2008-12-17
EP1444198A1 (en) 2004-08-11
WO2003037850A1 (en) 2003-05-08
AU2002330774B2 (en) 2009-06-04
CA2464648A1 (en) 2003-05-08
FIU20020420U0 (fi) 2002-10-23
DE20216779U1 (de) 2003-09-04
US6965051B2 (en) 2005-11-15
CZ13392U1 (cs) 2003-06-24
AU2002330774B9 (en) 2010-01-07
IS6603A (is) 2003-05-02
CH697164A5 (de) 2008-05-30
US20050096394A1 (en) 2005-05-05
FI5957U1 (fi) 2003-09-30
EP1444199A1 (en) 2004-08-11
DK200200339U1 (da) 2003-01-31
DE20216835U1 (de) 2003-09-25
US20030109752A1 (en) 2003-06-12
CN1578762A (zh) 2005-02-09
CZ13580U1 (cs) 2003-08-18
US6835853B2 (en) 2004-12-28
CH697034A5 (de) 2008-03-31
FIU20020421U0 (fi) 2002-10-23
CH696665A5 (de) 2007-09-14
CA2464648C (en) 2009-07-14
IL161449A0 (en) 2004-09-27
CN100343227C (zh) 2007-10-17
DE60230438D1 (de) 2009-01-29
FR2832147A1 (fr) 2003-05-16
CN1578761A (zh) 2005-02-09
FR2832146B1 (fr) 2006-05-26
AT6687U1 (de) 2004-02-25
NL1021678C2 (nl) 2003-05-15
WO2003037851A1 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
SG122743A1 (en) Microelectronic devices and methods of manufacture
IL161490A0 (en) Racemic tamsulosin free base and methods of making the same
AU2002364528A8 (en) Bio-implant and method of making the same
PL375691A1 (en) Imidazolopyridines and methods of making and using the same
SG107123A1 (en) Display and method of manufacturing the same
EP1411748A4 (en) SPEAKER AND METHOD FOR THE PRODUCTION THEREOF
EP1423120A4 (en) 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF
EP1554378A4 (en) PROTEASES PRODUCING MODIFIED IMMUNOGEN RESPONSE AND METHODS OF PRODUCTION AND USE
EP1424590A4 (en) DISPLAY DEVICE AND METHOD FOR MANUFACTURING THE SAME
EP1438387A4 (en) METHODS OF MAKING GLYCOMOLECULES WITH IMPROVED ACTIVITY, AND USES THEREOF
AU148030S (en) Pedestal
AU2002312315A8 (en) Microfabricated surgical devices and methods of making the same
IL159215A0 (en) A solution of interleukin-13 and methods utilizing the same
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
EP1418194A4 (en) MODIFIED POLYALKYLENEIMINE AND METHODS OF USE
IL160794A0 (en) An enantiomerically pure diarylmethylpiperazine and methods of using same
DE60232751D1 (de) Steckverbinder und Stecker
GB0127573D0 (en) Semiconductor optical devices and methods of making them
ITMI20021739A1 (it) Procedimento ed apparecchiatura per la produzione di
GB2394359B (en) Microelctronic device and method of its manufacture
EP1435953A4 (en) ANTI-VESICANS COMPOUNDS AND METHOD FOR THEIR PREPARATION AND USE
AU146999S (en) Base
HUP0402273A3 (en) Plant reproduction polynucleotides and methods of use
TW575136U (en) Lamp base